Abstract
In a patient with severe myoclonic epilepsy of infancy (SMEI), we identified a de novo balanced translocation, t(2;5)(q24.3,q34). The breakpoint on chromosome 2q24.3 truncated the SCN1A gene and the 5q34 breakpoint was within a highly conserved genomic region. Point mutations or microdeletions of SCN1A have previously been identified in SMEI patients, but this is the first report of a balanced translocation disrupting the SCN1A gene in an epilepsy patient. We therefore recommend that SMEI patients without SCN1A microdeletions or point mutations should be investigated for chromosomal rearrangements.
MeSH terms
-
Adolescent
-
Adult
-
Brain / pathology
-
Child
-
Child, Preschool
-
Chromosome Breakage
-
Chromosome Deletion
-
Chromosomes, Human, Pair 2 / genetics*
-
Chromosomes, Human, Pair 5 / genetics*
-
Disease Progression
-
Epilepsies, Myoclonic / diagnosis
-
Epilepsies, Myoclonic / genetics*
-
Epilepsies, Myoclonic / pathology
-
Follow-Up Studies
-
Humans
-
Infant
-
Intellectual Disability / genetics
-
Intellectual Disability / pathology
-
Karyotyping
-
NAV1.1 Voltage-Gated Sodium Channel
-
Nerve Tissue Proteins / genetics*
-
Phenotype
-
Point Mutation
-
Sodium Channels / genetics*
-
Spasms, Infantile / diagnosis
-
Spasms, Infantile / genetics
-
Spasms, Infantile / pathology
-
Status Epilepticus / diagnosis
-
Status Epilepticus / genetics
-
Status Epilepticus / pathology
-
Translocation, Genetic / genetics*
Substances
-
NAV1.1 Voltage-Gated Sodium Channel
-
Nerve Tissue Proteins
-
SCN1A protein, human
-
Sodium Channels